[P1–052]: CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4 HOMOZYGOTES WITH MILD TO MODERATE ALZHEIMER'S DISEASE (AD) ARE SUSTAINED OVER 130 WEEKS: RESULTS OF A PHASE 3 EXTENSION STUDY. (1st July 2017) - Abushakra, Susan; Sadowsky, Carl H.; Porsteinsson, Anton P.; Gauthier, Serge; Vellas, Bruno; Power, Aidan; Shen, Larry; Wang, Peter; Hey, John; Tolar, Martin